Medicare Enrolled

Dr. Susanne Gonzalez-Gallardo, MD

Neurology · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
13300 HARGRAVE RD STE 500, Houston, TX 77070
2817371167
In practice since 2010 (15 years)
NPI: 1609192814 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gonzalez-Gallardo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gonzalez-Gallardo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gonzalez-Gallardo

Dr. Susanne Gonzalez-Gallardo is a neurology in Houston, TX, with 15 years in practice. Based on federal Medicare data, Dr. Gonzalez-Gallardo performed 960 Medicare services across 639 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gonzalez-Gallardo received a total of $15,213 from 57 pharmaceutical and/or device companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gonzalez-Gallardo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 32% volume in TX$ $15,213 industry payments

Medicare Practice Summary

Medicare Utilization ↗
960
Medicare services
Top 32% in TX for neurology
639
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~64 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Needle measurement of electrical activity in arm or leg muscles, complete study517$79$300
Nerve conduction, 9-10 studies100$167$670
Nerve conduction, 11-12 studies88$197$787
Office visit, established patient (30-39 min)88$98$236
Nerve conduction, 13 or more studies46$227$909
Office visit, established patient, complex (40-54 min)35$126$316
Office visit, established patient (20-29 min)24$58$159
Nerve conduction, 7-8 studies23$134$555
Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes14$12$47
New patient office visit (45-59 min)13$115$363
Needle measurement of electrical activity in arm or leg muscles, limited study12$50$200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,213
Total received (2018-2024)
Avg $2,173/year across 7 years
Top 21% in TX for neurology
57
Companies
490
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,979 (59.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,736 (31.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,497 (9.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,666
2023
$1,258
2022
$1,342
2021
$5,195
2020
$1,709
2019
$2,657
2018
$386

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$2,523
AbbVie Inc.
$2,186
UCB, Inc.
$1,548
Alexion Pharmaceuticals, Inc.
$1,312
LivaNova USA, Inc.
$977
ABBVIE INC.
$822
Novartis Pharmaceuticals Corporation
$648
CSL Behring
$565
Teva Pharmaceuticals USA, Inc.
$375
GENZYME CORPORATION
$364
ACADIA Pharmaceuticals Inc
$353
Grifols USA, LLC
$334
Abbott Laboratories
$261
Eisai Inc.
$190
Genentech USA, Inc.
$177
ARGENX US, INC.
$171
Amgen Inc.
$167
SK Life Science, Inc.
$167
Lilly USA, LLC
$141
JAZZ PHARMACEUTICALS INC.
$127
Biogen, Inc.
$122
PFIZER INC.
$121
Neurocrine Biosciences, Inc.
$109
Allergan Inc.
$105
Amneal Pharmaceuticals LLC
$104
Takeda Pharmaceuticals U.S.A., Inc.
$104
CATALYST PHARMACEUTICALS, INC.
$101
EISAI INC.
$81
Upsher-Smith Laboratories LLC
$74
Acorda Therapeutics, Inc
$65
Jazz Pharmaceuticals Inc.
$55
Lundbeck LLC
$51
GE HEALTHCARE
$50
DePuy Synthes Sales Inc.
$47
Biohaven Pharmaceuticals, Inc.
$46
Avanir Pharmaceuticals, Inc.
$46
PORTOLA PHARMACEUTICALS, LLC
$42
ARBOR PHARMACEUTICALS, INC.
$41
Kyowa Kirin, Inc.
$40
iRhythm Technologies, Inc.
$34
Biohaven Pharmaceutical Holding Company Ltd.
$34
Mallinckrodt Enterprises LLC
$32
Averitas Pharma Inc.
$29
Ultragenyx Pharmaceutical Inc.
$27
Supernus Pharmaceuticals, Inc.
$26
Promius Pharma LLC
$25
Adamas Pharmaceuticals, Inc.
$24
Silk Road Medical, Inc.
$23
MERZ NORTH AMERICA, INC.
$19
AQUESTIVE THERAPEUTICS, INC.
$19
Scilex Pharmaceuticals Inc.
$17
Vertical Pharmaceuticals, LLC
$17
EMD Serono, Inc.
$17
GRT US Holding, Inc.
$16
Harmony Biosciences LLC
$15
IMPEL PHARMACEUTICALS INC.
$14
Mallinckrodt Hospital Products Inc.
$12
Top 3 companies account for 41.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · ANDEXXA · AUBAGIO · AUSTEDO · Activase · Aimovig · Austedo XR · BOTOX · BOTOX COSMETIC · Briviact · COMIRNATY · DIVIGEL · Dojolvi · EMGALITY · ENROUTE Transcarotid Stent · Evekeo · Evrysdi · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · Leqembi · MATRIXNEURO · MAVENCLAD · MAYZENT · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · ONGENTYS · Ocrevus · POMPE - DISEASE · PROCLAIM · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RYTARY · Repatha · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XEOMIN · XYREM · XYWAV · ZEMBRACE SYMTOUCH · ZTLido · Zilbrysq · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,585 per 100 Medicare services performed
Looking for a neurology in Houston?
Compare neurologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
362
Per 100K population
7.6
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gonzalez-Gallardo is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gonzalez-Gallardo experienced with needle measurement of electrical activity in arm or leg muscles, complete study?
Based on Medicare claims data, Dr. Gonzalez-Gallardo performed 517 needle measurement of electrical activity in arm or leg muscles, complete study services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gonzalez-Gallardo receive payments from pharmaceutical companies?
Yes. Dr. Gonzalez-Gallardo received a total of $15,213 from 57 companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gonzalez-Gallardo's costs compare to other neurologys in Houston?
Dr. Gonzalez-Gallardo's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gonzalez-Gallardo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →